Nick de Cent
Nick de Cent
Latest posts from :
Although many pharma companies acknowledge the need to move to more...
eyeforpharma asked Joel Beetsch, Vice President of Patient Advocacy at Celgene,...
From new healthcare products to the way we conduct clinical trials, “big...
Clinical trials represent one important area where digitization is set to...
If you want to engage patients, it’s important to tell a compelling story,...
2014 has witnessed an important change in sentiment among pharma companies...
Formulary Development Pharmacist for NHS England in the Surrey and Sussex...
Pharma marketing is changing as companies recognize the need to communicate on...
Pharma is still not speaking the language of payers, despite attempts to engage...
Are digital health platforms set to make a greater impact than the majority of...